Virtus ETF Advisers LLC Halozyme Therapeutics, Inc. Transaction History
Virtus ETF Advisers LLC
- $70.5 Million
- Q1 2025
A detailed history of Virtus ETF Advisers LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,690 shares of HALO stock, worth $142,058. This represents 0.24% of its overall portfolio holdings.
Number of Shares
2,690
Previous 7,310
63.2%
Holding current value
$142,058
Previous $349,000
51.0%
% of portfolio
0.24%
Previous 0.15%
Shares
29 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$931 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$678 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$320 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$206 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$194 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.36B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...